July 24, 2013
- VISIUS iCT establishes level of intraoperative imaging previously unavailable
to surgeons IMRIS
Inc. today announced US Food and Drug Administration (FDA) 510K clearance
to market VISIUS iCT, a ceiling-mounted intraoperative
computed tomography (iCT) on the market.
scanner is designed for the hybrid
operating room (OR), particularly for the spinal and neurosurgical market. VISIUS
iCT is a surgical theater that provides personalized dose management together
with diagnostic quality imaging during the surgical procedure to assist
surgeons in critical decision making. The 64-slice scanner effortlessly moves
into and out of the operating room during surgery using ceiling-mounted rails
to ease workflow. This enables multiple room configurations to meet both
clinical requirements and increase utilization without compromising image
quality or exam speed.
transport and the need for floor-mounted rails used in other systems is
eliminated, which opens up OR
space and allows movement of surgical equipment and simplified infection
control. The system also offers a long scanner travel range.
iCT provides surgeons with on-demand CT imaging to enhance decision making, and
both guide and confirm implant placement. The spine surgery market represents a
new opportunity for IMRIS and VISIUS iCT establishes a level of intraoperative
imaging previously unavailable to surgeons and patients," said David
Graves, IMRIS CEO.
VISIUS iCT features a suite of software applications such as 3-dimensional (3D)
volume rendering to aid in surgical planning and dose reduction, which
considers each patient’s unique characteristics and needs to maximize image
quality and minimize dose. The software allows health care practitioners to
visualize dosage prior to scan and adjust settings based on the specific
clinical need with detailed dosage reports produced after each scan.
information: www.IMRIS.com and www.appliedradiology.com